Depression and bipolar disorder: relationships to impaired fatty acid and phospholipid metabolism and to diabetes, cardiovascular disease, immunological abnormalities, cancer, ageing and osteoporosis - Possible candidate genes

被引:174
作者
Horrobin, DF [1 ]
Bennett, CN [1 ]
机构
[1] Laxdale Res, Stirling FK7 9JQ, Scotland
来源
PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS | 1999年 / 60卷 / 04期
关键词
D O I
10.1054/plef.1999.0037
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Depression and bipolar disorder are two of the commonest illnesses in the developed world, While some patients can bt! treated effectively with available drugs, many do not respond, especially in the depression related to bipolar disorder. Depression is associated with diabetes, cardiovascular disease, immunological abnormalities, multiple sclerosis, cancer, osteoporosis and ageing: in each case depressed individuals have a worse outcome than non-depressed individuals. In all of these conditions there is now evidence of impaired phospholipid metabolism and impaired fatty acid-related signal transduction processes. Impaired fatty acid and phospholipid metabolism may be a primary cause of depression in many patients and may explain the interactions with other diseases. Several novel gene candidates for involvement in depression and bipolar disorder are proposed.
引用
收藏
页码:217 / 234
页数:18
相关论文
共 254 条
[11]   Relation between depression and circulating immune products in patients with advanced colorectal cancer [J].
Allen-Mersh, TG ;
Glover, C ;
Fordy, C ;
Henderson, DC ;
Davies, M .
JOURNAL OF THE ROYAL SOCIETY OF MEDICINE, 1998, 91 (08) :408-413
[12]  
Amato L, 1996, DIABETES METAB, V22, P314
[13]   The immune system and major depression [J].
Anderson, JL .
ADVANCES IN NEUROIMMUNOLOGY, 1996, 6 (02) :119-129
[14]  
ANSELL D, 1986, LANCET, V2, P509
[15]   CSF PROSTAGLANDIN-E IN AGORAPHOBIA WITH PANIC ATTACKS [J].
ANTON, RF ;
BALLENGER, JC ;
LYDIARD, RB ;
LARAIA, MT ;
HOWELL, EF ;
GOLD, PW .
BIOLOGICAL PSYCHIATRY, 1989, 26 (03) :257-264
[16]   The role of corticotropin-releasing factor in depression and anxiety disorders [J].
Arborelius, L ;
Owens, MJ ;
Plotsky, PM ;
Nemeroff, CB .
JOURNAL OF ENDOCRINOLOGY, 1999, 160 (01) :1-12
[17]   Structural and functional characterization of the human CD36 gene promoter - Identification of a proximal PEBP2/CBF site [J].
Armesilla, AL ;
Calvo, D ;
Vega, MA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (13) :7781-7787
[18]   DEPRESSION AND CARDIOVASCULAR-DISEASES [J].
AROMAA, A ;
RAITASALO, R ;
REUNANEN, A ;
IMPIVAARA, O ;
HELIOVAARA, M ;
KNEKT, P ;
LEHTINEN, V ;
JOUKAMAA, M ;
MAATELA, J .
ACTA PSYCHIATRICA SCANDINAVICA, 1994, 89 :77-82
[19]   INHIBITION OF CALCIUM-INDEPENDENT PHOSPHOLIPASE A(2) PREVENTS ARACHIDONIC-ACID INCORPORATION AND PHOSPHOLIPID REMODELING IN P388D(1) MACROPHAGES [J].
BALSINDE, J ;
BIANCO, ID ;
ACKERMANN, EJ ;
CONDEFRIEBOES, K ;
DENNIS, EA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (18) :8527-8531
[20]   Symptoms of depression, acute myocardial infarction, and total mortality in a community sample [J].
Barefoot, JC ;
Schroll, M .
CIRCULATION, 1996, 93 (11) :1976-1980